These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28083604)

  • 21. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection.
    Yu AQ; Ding Y; Lu ZY; Hao YZ; Teng ZP; Yan SR; Li DS; Zeng Y
    Mol Med Rep; 2018 Jan; 17(1):243-249. PubMed ID: 29115572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection.
    Grimaldi R; Shindo N; Acosta AX; Dourado I; Brites C; de Melo Carvalho O; Brito I; Bou-Habib DC; Galvão-Castro B
    Hum Genet; 2002 Jul; 111(1):102-4. PubMed ID: 12136242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [CYP2D6, CYP3A5, and CYP3A4 gene polymorphism in Russian, Tatar, and Bashkir populations].
    Mustafina OE; Tuktarova IA; Karimov DD; Somova Rs; Nasibullin TR
    Genetika; 2015 Jan; 51(1):109-19. PubMed ID: 25857198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
    Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
    Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.
    Kamkamidze G; Capoulade-Metay C; Butsashvili M; Dudoit Y; Chubinishvili O; Debre P; Theodorou L
    Georgian Med News; 2005 Jan; (118):74-9. PubMed ID: 15821335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The HIV-infection outbreak in the town Lys'va (Perm region): homozygote genotype CCR5 delta32/CCR5 delta32 provides the high level of the persistence in the parenteral transmission of the virus].
    Riabov GS; Kazennova EV; Korepanova LB; Mal'tseva EA; Zhalnin VV; Krasnikova LA; Zverev SIa; Pokrovskiĭ VV; Bobkov AF; Weber JN
    Vopr Virusol; 2002; 47(4):13-6. PubMed ID: 12271718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and frequency of CCR5Δ32/Δ32 HIV-resistant cord blood units from Houston area hospitals.
    Gonzalez G; Park S; Chen D; Armitage S; Shpall E; Behringer R
    HIV Med; 2011 Sep; 12(8):481-6. PubMed ID: 21375684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the genetic variant CCR5Δ32 in HBV infection and HBV/HIV co-infection.
    Ellwanger JH; Kulmann-Leal B; Wolf JM; Michita RT; Simon D; Lunge VR; Chies JAB
    Virus Res; 2020 Feb; 277():197838. PubMed ID: 31837381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan.
    Fatima F; Saleem S; Hameed A; Haider G; Ali Zaidi SA; Kanwal M; Zehra S; Azhar A
    Mol Biol Rep; 2019 Apr; 46(2):2387-2394. PubMed ID: 30848448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimen.
    Brumme ZL; Henrick BM; Brumme CJ; Hogg RS; Montaner JS; Harrigan PR
    Antivir Ther; 2005; 10(7):849-53. PubMed ID: 16312181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection.
    Kim A; Pettoello-Mantovani M; Goldstein H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):145-9. PubMed ID: 9768623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of CCR5Δ32 mutation in protecting patients with Schistosoma mansoni infection against hepatitis C viral infection or progression.
    El-Moamly AA; El-Sweify MA; Rashad RM; Abdalla EM; Ragheb MM; Awad MM
    Parasitol Res; 2013 Jul; 112(7):2745-52. PubMed ID: 23515570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the CCR5∆32 frequency in Emiratis and Tunisians and the screening of the CCR5 gene for novel alleles in Emiratis.
    Al-Jaberi SA; Ben-Salem S; Messedi M; Ayadi F; Al-Gazali L; Ali BR
    Gene; 2013 Oct; 529(1):113-8. PubMed ID: 23933274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of the cytochrome P450 (CYP1A1) gene polymorphism in the ethnic groups of the Republic of Bashkortostan].
    Kochetova OV; Korytina GF; Akhmadishina LZ; Iskhakov GM; Victorova TV
    Genetika; 2008 Dec; 44(12):1677-83. PubMed ID: 19178087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease.
    Atzeni F; Boiardi L; Casali B; Farnetti E; Nicoli D; Sarzi-Puttini P; Pipitone N; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Filippini D; Paolazzi G; Salvarani C
    Rheumatology (Oxford); 2012 Dec; 51(12):2141-5. PubMed ID: 22966075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of heterozygous CCR5Δ32 deletion with survival in HIV-infection: A cohort study.
    Ruiz-Mateos E; Tarancon-Diez L; Alvarez-Rios AI; Dominguez-Molina B; Genebat M; Pulido I; Abad MA; Muñoz-Fernandez MA; Leal M
    Antiviral Res; 2018 Feb; 150():15-19. PubMed ID: 29221798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and the role of CCR5Δ32 heterozygosity in disease progression in HIV positive patients in the Czech Republic.
    Sácká L; Hodek J; Machala L; Malý M; Weber J
    Epidemiol Mikrobiol Imunol; 2019; 68(3):138-143. PubMed ID: 31914779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison CCR5de132 mutation in the CCR5 gene frequencies in Russians, Tuvinians, and in different groups of HIV-infected individuals].
    Apriatin SA; Rakhmanaliev ER; Nikolaeva IA; Ruban SV; Vazykhova FG; Klimov EA; Sulimova GE; Sidorovich IG
    Genetika; 2005 Nov; 41(11):1559-62. PubMed ID: 16358723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.